Key facts
- It has raised $3.0M across 3 recorded rounds; the latest was Seed Round ($725K) in Oct 2025.
- Notable investors include MassChallenge, Medical Forge, Merage Institute.
- NeuroTrigger has filed 2 Form Ds with the SEC since 2023, most recently Apr 2025 ($520K sold to 6 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 3 rounds
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for NeuroTrigger
Funding rounds
3 roundsAbout NeuroTrigger
Developer of a wearable muscle stimulator designed to improve or facilitate muscle performance by delivering electrical pulses to the muscles. The company's product specializes in rechargeable stimulators and a pre-gelled Y-shaped electrode that attaches to the stimulator by a magnetic flap and generates electrical pulses that are transmitted to the muscles through the electrode, causing the muscles to contract, enabling patients to self-administer muscle stimulation therapy at home or in the clinic.
- Sector
- Healthcare
- HQ
- Raanana, Israel
- Founded
- 2018
- Employees
- 6
- Website
- nt-med.com/
- Ownership
- Privately Held (backing)
NeuroTrigger doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in NeuroTrigger shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on NeuroTrigger in its N-PORT filings yet. We sweep new filings monthly.